Pharmaceutical company backed by Austin angel investors files for IPO


In total dollars and number of investors, the CTAN investment in Xeris Pharmaceuticals is the organization’s third-largest to date. About 30 members have invested in Xeris, according to CTAN Executive Director Claire England.

Previous Amid restructuring, Deutsche Bank not commenting on local impact
Next As the M&A market heats up, middle market companies are cashing in